U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07366099) titled 'Al18F-NOTA-LM3 PET/CT in Patients With TIO' on Jan. 18.
Brief Summary: This is a pilot study to assess the value of whole-body Al18F-NOTA-LM3 PET/CT in patients with tumor-induced osteomalacia.
Study Start Date: March 30, 2023
Study Type: INTERVENTIONAL
Condition:
Tumor-Induced Osteomalacia
Intervention:
DRUG: Diagnostic Test: Al18F-NOTA-LM3
Al18F-NOTA-LM3 will be injected into the patients. Patients will undergo a whole-body PET/CT scan 60-120 minutes after injection.
DRUG: Diagnostic Test: 68Ga-DOTATATE
68Ga-DOTATATE will be injected into the patients. Patients will undergo a whole-body PET/CT scan 40-60 minutes after inj...